Immuneering Corporation - Class A Common Stock (IMRX)

Immuneering (IMRX) Q3 2025 Earnings Transcript

Boston, MA – September 27, 2025 – Immuneering Corporation (NASDAQ: IMRX) experienced a significant downturn in its stock value on September 25, 2025, with shares declining by approximately 13.3%. This notable drop came on the heels of the company's announcement and pricing of a substantial public stock offering, a move that

Gainers PepGen (NASDAQ: PEPG) shares rose 141.0% to $6.41 during Thursday's pre-market session. The market value of their outstanding shares is at $87.2 million.

Shares of PepGen Inc. (NASDAQ: PEPG) rose sharply in pre-market trading after the company announced the launch of an underwritten public offering of common stock and pre-funded warrants.

After the closing bell on Wednesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.

Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements.

Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements.

Let's have a look at what is happening on the US markets on Thursday. Below you can find the gap up and gap down stocks in today's session.

After the closing bell on Wednesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.

The trading volume of these stocks is deviating from the norm in today's session.

Let's have a look at the stocks with an unusual volume in today's session.